Iomeron

Iomeprol, the active ingredient in Iomeron, is a non‑ionic iodinated contrast media presented as a solution for injection for intraarterial, intraarticular, and intravenous use. It provides radiographic contrast by increasing X‑ray attenuation, enabling clearer visualization of vascular structures and tissues during diagnostic imaging procedures. Iomeron is employed in patients undergoing angiography, arthrography, computed tomography and other contrast‑enhanced studies.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Iomeron is used as a radiographic contrast agent to improve image quality in several diagnostic pathways. - Angiography: enhances vascular visualization to aid diagnosis and interventional procedures. - Arthrography: delineates joint spaces and soft‑tissue structures for orthopedic assessment. - Computed tomography (CT) imaging: increases organ and vessel contrast for more accurate detection of pathology.

Adverse reactions may occur following administration of Iomeron.

Common Side Effects: - Warmth or flushing sensation during injection. - Metallic taste in the mouth. - Nausea or mild vomiting. - Headache or dizziness. - Transient urticaria or mild skin rash. - Mild increase in serum creatinine.

Serious or Rare Side Effects: - Severe allergic reaction or anaphylaxis. - Acute renal failure, especially in patients with pre‑existing kidney disease. - Cardiopulmonary arrest or severe hypotension. - Seizures or neurological disturbances. - Pulmonary edema. - Persistent skin necrosis at injection site.

Before using Iomeron, clinicians should assess patient risk factors and follow safety guidelines. - Renal function assessment: evaluate baseline kidney function and consider alternative agents in severe impairment. - Allergy history: screen for prior reactions to iodinated contrast or iodine‑containing substances. - Metformin use: discontinue metformin in at‑risk patients with reduced renal clearance before and after administration. - Thyroid disease: monitor thyroid function in patients with hyperthyroidism or thyroid nodules. - Pregnancy and lactation: use only if the diagnostic benefit outweighs potential fetal or neonatal risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Iomeron may interact with certain medications and conditions; awareness helps mitigate risk.

Major Interactions (Avoid): - Metformin in patients with impaired renal function: increased risk of lactic acidosis. - Radioactive iodine therapy: may interfere with thyroid uptake and treatment efficacy. - High‑dose steroids: can mask early signs of an allergic reaction.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate contrast‑induced nephropathy. - ACE inhibitors or ARBs: monitor renal function closely when combined with contrast. - Beta‑blockers: may affect hemodynamic response during intra‑arterial injection.